Jere D. Fellmann

Jere D. Fellmann

Corporate Officer/Principal chez KYTHERA BIOPHARMACEUTICALS INC

72 ans
Health Technology
Technology Services
Finance

Profil

Jere D.
Fellmann
is the founder of Ocellus, Inc. (founded in 1996) where he holds the title of Director.
He is currently working at Kythera Biopharmaceuticals LLC as Vice President-Clinical Operations since 2012.
In his former positions, Dr. Fellmann worked as Principal at Neurex Corp., Symyx Technologies, Inc., and Elan Pharmaceuticals, LLC.
He also served as Vice President-Clinical Operations at Acologix, Inc. from 2005 to 2007 and at Eunoe, Inc. from 2000 to 2004.
Additionally, Dr. Fellmann worked as Principal at Fougera Pharmaceuticals, Inc. Dr. Fellmann holds a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from the University of California, Berkeley.

Postes actifs de Jere D. Fellmann

SociétésPosteDébut
KYTHERA BIOPHARMACEUTICALS INC Corporate Officer/Principal 01/06/2012
Ocellus, Inc. Fondateur 01/01/1996
Tous les postes actifs de Jere D. Fellmann

Anciens postes connus de Jere D. Fellmann

SociétésPosteFin
Directeur des opérations 01/09/2007
Directeur des opérations 01/10/2004
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Jere D. Fellmann

Formation de Jere D. Fellmann

Massachusetts Institute of Technology Doctorate Degree
University of California, Berkeley Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Jere D. Fellmann

Relations

35

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées8

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Ocellus, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Jere D. Fellmann
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT